Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2018-01-19

Clinical Trial Update: Ketamine vs. Placebo as Adjunctive Therapies for Severe Alcohol Withdrawal [Phase 4]

View source ↗

Summary

Phase 4 trial comparing ketamine to placebo as adjunctive therapy for severe alcohol withdrawal was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Alcohol Withdrawal | Phase 4 | Status: WITHDRAWN